|
⚲
|
| Birchview Capital LP
✚
|
|
|---|---|
| CRD # | 170534 |
| SEC # | 801-79710 |
| CIK # | 0001618205 |
| AUM | $239.1 M (2026-03-31) |
| Employees | 6 (83% Investors, 0% Brokers) |
| Phone | 802-923-3826 |
| Address | 688 Pine Street Burlington, VT 05401 |
| Source | [IAPD] [EDGAR] [Website] |
| Total AUM ($M) |
|---|
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| KLA Tencor Corp | 29.3 | ||
| Bristol Myers Squibb Co | 18.6 | ||
| Olivia Ventures Inc | 7.8 | ||
| Lam Research Corp | 7.7 | ||
| Stoke Therapeutics Inc | 6.8 | ||
| Ovintiv Inc | 6.4 | ||
| Intellia Therapeutics Inc | 5.7 | ||
| Structure Therapeutics Inc | 4.8 | ||
| Quidelortho Corp | 4.8 | ||
| Solid Biosciences Inc | 4.5 | ||
| View All | |||
| Holdings by Sector ($M) |
|---|
| Type | Form D Funds | Date | Sold ($M) | AUM ($M) |
|---|---|---|---|---|
| PE | Monteris BC Holdings 6 LLC | [2023-03-22] | 1.5 | 2.5 |
| PE | Monteris BC Holdings 7 LLC | [2023-03-22] | 5.5 | 3.8 |
| PE | Birchview Capital VF III LLC | [2021-09-29] | 3.5 | 4.2 |
| PE | Monteris BC Holdings 5 LLC | [2021-03-30] | 29.7 | 4.2 |
| PE | Monteris BC Holdings 4 LLC | [2020-06-12] | 3.0 | 0.0 |
| PE | Ed BC Holdings 3 LLC | [2020-03-30] | 8.1 | 0.0 |
| PE | Monteris BC Holdings 3 LLC | [2019-03-20] | 6.6 | 0.0 |
| PE | Monteris BC Holdings 2 LLC | [2017-08-24] | 4.3 | 0.0 |
| PE | Ed BC Holdings LLC | [2017-03-31] | 0.6 | 0.0 |
| PE | Monteris BC Note LLC | [2017-03-31] | 6.2 | 0.0 |
| View All | ||||
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.7 |
| (b) Individuals (high net worth individuals) | 0 | 126.1 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 12 | 112.3 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 16 | 239.1 |
| By Discretionary | ||
| Discretionary | 16 | 239.1 |
| Non-Discretionary | 0 | 0.0 |
| Total | 16 | 239.1 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.0 | |
| United States Persons | 239.1 | |
| Total | 16 | 239.1 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Jack Schuler | 45 | 2 | ||
| Matthew Strobeck | 36 | 2 | ||
| Birchview Capital LP | 9 | 2 | ||
| Richard McCormick | 6 | 2 | ||
| Birchview Partners LLC | 2 | 2 | ||
| William Scully | 1 | 1 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001618205] | |
| 3 | [0001618205] | |
| 4 | [0001618205] | |
| SC 13G | [0001618205] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Birchview Capital LP | Aziyo Biologics Inc | [2021-12-17] |
| Birchview Capital LP | Soleno Therapeutics Inc | [2017-12-26] |
| Birchview Capital LP | Hansen Medical Inc | [2015-03-19] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Birchview Fund LLC | |
| Strobeck Matthew | |
| Elutia Inc | |
| Birchview Capital, LP | |
| Birchview Partners, LLC | |
| Birchview Capital GP, LLC | |
| Yield10 Bioscience Inc |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Compass Financial Advisors LLC
✚
|
IN | 0.3 |
|
Hallador Investment Advisors Inc
✚
|
NV | 0.3 |
|
Fuller Investment Management Company
✚
|
CA | 0.3 |
|
ELCO Management Company LLC
✚
|
NY | 0.3 |
|
Zephyr Management LP
✚
|
NY | 0.3 |
|
Vantage Consulting Group Inc
✚
|
VA | 0.2 |
|
Welcy Capital Advisors LLC
✚
|
FL | 0.2 |
|
Open Field Capital LLC
✚
|
NY | 0.2 |
|
MB Family Advisors LLC
✚
|
NY | 0.2 |
|
CIG Asset Management Inc
✚
|
MI | 0.2 |